Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients

Interferon-alpha (IFN-α) therapy of chronic hepatitis B (CHB) patients is constrained by limited response and side effects. We described a panel of circulating microRNAs (miRNAs) which could potentially predict outcome of IFN-α therapy. Here, we report development of a simplified scoring model for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jin, Zhang, Xiaonan, Chen, Liang, Zhang, Zhanqing, Zhang, Jiming, Wang, Weixia, Wu, Min, Shi, Bisheng, Zhang, Xinxin, Kozlowski, Maya, Hu, Yunwen, Yuan, Zhenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688172/
https://www.ncbi.nlm.nih.gov/pubmed/29142236
http://dx.doi.org/10.1038/s41598-017-15594-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688172/
https://www.ncbi.nlm.nih.gov/pubmed/29142236
http://dx.doi.org/10.1038/s41598-017-15594-0

Ejemplares similares